PreludeDx
Curated by SignalProvider of risk assessment test for early stage breast cancer
Overview
Provider of risk assessment tests for early-stage breast cancer. The flagship product DCISionRT is targeted at patients who have breast cancer staged at ductal carcinoma in situ (DCIS). The company uses a panel of disease-associated biomarkers and proprietary algorithms to classify DCIS patients into high-risk and low-risk categories. The system has features for predicting the treatment for cancer patients as well.
Key facts
- Founded
- 2009
- Headquarters
- Laguna Hills, United States
- Stage
- Sign up to view
- Industry
- Health Technology
Business model
- 1 product or service
- Sign up to view
Contact
- Primary office
- Sign up to view
- Sign up to view
Open roles
7 rolesRegional Sales Specialist - Los Angeles
Laguna Hills, CA · On-site · Internship
Histotechnician/Histotechnologist
Laguna Hills, CA · On-site · Volunteer
Biostatistician – Machine Learning & Bioinformatics
Laguna Hills, CA · On-site · Volunteer